Group Action Lawyers
Latest News & Updates

Tag: recalls

drugs alert
March 25, 2019
Are you suffering with valsartan side effects?

If you’re suffering with valsartan side effects, you may want to read this article and take heed of some important information about the drug.

Last year, a Class 1 Medicines Recall was initiated by Medicines and Healthcare products Regulatory Agency (MHRA). The recall stems from potential contamination that comes from the production process that could be incredibly serious for anyone affected. In fact, in the US, lawsuits have been active for some time now. When members of the Group Action Lawyers attended a conference in the U.S. last year, it was clear to us just how serious this issue could be.

If you’ve been taking the medication here in the UK and you’ve suffered problems or side effects, we may need to speak with you.

Continue Reading…

eye claims
January 24, 2019
Oculentis compensation action

If you’ve yet to initiate your legal action for Oculentis compensation, make sure you speak to our team as soon as you possibly can.

In this type of action, there can be complicated (and multiple) time limits to claim. Missing one or more of these deadlines could mean the difference between receiving thousands of pounds in compensation or getting absolutely nothing at all.

You may be eligible to claim Oculentis compensation if you’re one of the hundreds of people affected by the recall of their intraocular lenses.

Continue Reading…

drug recall
December 07, 2018
Valsartan recall widens

The Valsartan recall widened last month following updated advice from the Medicines and Healthcare Regulatory Authority (MHRA).

Batches of products containing Valsartan that were supplied by Teva UK Ltd and Mylan are being recalled in the UK. This follows on from a drug alert earlier this year that was issued after the discovery that some Valsartan products were contaminated. Legal cases are already underway, and this latest recall involves further batches of the product.

An immediate suspension and quarantine of the additional affected products has been ordered.

Continue Reading…

defective product claims
November 30, 2018
Were you affected by the cough syrup mould recall?

Were you affected by the cough syrup mould issues that came to light over summer? In the midst of the season for colds and coughs, you may want to take heed of this warning if you’re not aware of it already.

Over summer, a formal recall was issued with the UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency. This was a Class 2 Medicines recall for own-brand glycerine and blackcurrant cough syrup products manufactured for children by Bell, Sons & Co.

As these are marketed as own-brand products, it’s the likes of Asda, Morrisons, Sainsbury’s and Tesco at the centre of this recall.

Continue Reading…

medical device recall
November 09, 2018
Bone cement complications from product recall

A regulator warning earlier this year stemmed from bone cement complications caused by an issue with the product itself.

A risk of the need for revision surgery from the use of Optipac 40 Refobacin Revision and Optipac 80 Refobacin Revision was identified. Manufacturer, Biomet UK Limited, issued a Field Safety Notice at the end of last year. The UK’s medical regulator, the MHRA (Medicines and Healthcare products Regulatory Agency), issued their own recall advice off the back of the findings.

Anyone who has suffered with bone cement complications may find the reason is to do with the product itself as opposed to failed surgery.

Continue Reading…

eye claims
September 07, 2018
Latanoprost Timolol eye drops recall

A Latanoprost Timolol eye drops recall has been announced by the Medicines and Healthcare Regulatory Authority (MHRA).

The company behind the eye drops, FDC Pharma, are recalling a batch due to what has been classed as an ‘out of specification result for an unknown impurity’ that was identified during testing. Medical professionals are to stop providing the eye drops to patients, and suppliers and distributors are to cease moving the eye drops as well.

The NHS has been pushing the news throughout the Service to ensure batches affected by the Latanoprost Timolol eye drops recall are not used.

Continue Reading…

unsatisfactory safety information
July 19, 2018
Phenytoin 90mg/5ml Oral Suspension immediate discontinuation

There has been an immediate discontinuation of unlicensed medicine Phenytoin 90mg/5ml Oral Suspension and a recall of the product.

The medication, manufactured by Rosemont Pharmaceuticals Limited, is now no longer on the shelves having been recalled and discontinued with immediate affect as a result of worrying data that suggested that the medication becomes difficult to resuspend over shelf-life.

Patients who use the Phenytoin 90mg/5ml Oral Suspension are being told to contact their doctors for more information and advice about the issues that have been identified.

Continue Reading…

medical alert
July 04, 2018
Roche Diabetes Care test strip errors leads to recall

Roche Diabetes Care test strip errors has led to a recall of a number of home-use and point-of-care glucose monitoring systems.

The Roche Diabetes Care test strip errors are for the following systems: Accu-Chek Aviva; Accu-Chek Performa; and Accu-Chek Inform II.

There is a risk of a strip error message that may lead to either falsely high or falsely low blood glucose results reported.

Continue Reading…

unsatisfactory safety information
June 15, 2018
Diabetes testing kit recall

News of a diabetes testing kit recall is said to be “urgent” amid fears of lives at risk over false readings.

The Accu-Chek Aviva and the Accu-Chek Performa are the diabetes testing kits being recalled that could lead to an overdose or an under-dose of insulin that can lead to serious health complications for users.

Advice to patients is to stop using the affected devices and return them to a pharmacy for a replacement.

Continue Reading…

unsatisfactory safety information
April 18, 2018
Resuscitation system recall issued after risk of damage to lungs found

An error with a resuscitation system has been reported to risk damage to lungs, according to information released by the Medicines and Healthcare Products Regulatory Agency (MHRA).

Manufactured by Intersurgical, the manual resuscitation system – named as the “Bag valve mask” (BVM) – risks damage to lungs due to the potential for excess pressure being delivered by the system.

Given that the defect is with a resuscitation system, this recall is an important one as lives may be at risk as a result of it.
Continue Reading…

medical device recall
April 06, 2018
Risks of infection for patients where Zimmer Biomet hip and trauma instruments are used

Zimmer Biomet have been in the news in recent years over knee replacement device problems, which is one of many stories where medical manufacturers have been in the spotlight for medical device compensation claims.

You only need to look at the massive Metal-on-Metal hip implant cases to see just how big these kinds of claims are.

In this latest story, Zimmer Biomet are recalling specific hip and trauma instruments over potential risks of infections to patients.
Continue Reading…

new government product safety office created
March 23, 2018
Group Action Lawyers welcome new government department to stop faulty product disasters

We welcome the creation of a new government office whose mission is to prevent future product disasters and potentially save lives as well as headaches for consumers in Britain when mass-recalls occur.

The initiative comes off the back of the monumental Whirlpool tumble dryer disaster that saw some three million products liable to catching fire from excess fluff building up in the drums. It’s estimated that around one million tumble dryers are still out there that remain dangerous. This new government office is designed to prevent future disasters of this nature as well as dealing with the fallout when such incidents occur.
Continue Reading…